Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01514331
Other study ID # 01/2011-68
Secondary ID
Status Completed
Phase N/A
First received December 20, 2011
Last updated November 19, 2013
Start date January 2012
Est. completion date November 2013

Study information

Verified date November 2013
Source Gazi University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to investigate effects of SIMV+VG (synchronized intermittent mandatory ventilation+volume guarantee) or PSV+VG (pressure support ventilation+volume guarantee) ventilation on vital signs, patient - mechanical ventilation synchrony, ventilation parameters and inflammatory mediators in neonates.


Description:

Term or preterm neonates may need mechanical ventilation due to different etiologies. In all patients aim of mechanical ventilation is to promote pulmonary gas exchange, reduce the respiratory work of patient. Ideal mechanical ventilation must minimize pulmonary trauma with low inspiratory pressures that obtains adequate and constant tidal volumes. Ventilation associated pulmonary injury is an important subject that must be considered during mechanical ventilation. Atelectotrauma, volutrauma, barotrauma and biotrauma must be monitored. Volutrauma, barotrauma and oxygen toxicity cause cytokine increase that results in biotrauma. This parenchymal inflammation is a risk factor for chronic lung disease which is an important morbidity of ventilated neonates.

From past to present neonates were ventilated with different ventilation modes including IMV (Intermittent Mandatory Ventilation), SIMV, A/C (Assist Control Ventilation), PSV,HFV (High Frequency Ventilation). Both PSV and SIMV are patient trigger ventilation modes but SIMV is a time cycled and PSV is a flow cycled mode. In recent years hybrid techniques were developed to combine beneficial features of volume and pressure limited ventilation. In commercial ventilation devices these techniques have different names as volume guaranteed pressure limited ventilation (Drager Babylog 8000), pressure regulated volume controlled ventilation (Siemens servo 3000), volume guaranteed pressure support ventilation (VIP Bird Gold).

Since there is not a standard protocol for mechanical ventilation of neonates different countries and even different NICU's use different ventilation protocols.

Literature supports volume targetted ventilation to reduce barotrauma with low maximum inspiratory pressures and to reduce volutrauma with constant tidal volumes. When A/C+VG and SIMV+VG were compared in a crossover trial, more constant tidal volumes were obtained in A/C mode. Inflammatory cytokines have also been measured in different groups of patients with variable ventilatory management techniques. So far there has not been a randomized study published comparing VG+SIMV with VG+PSV in newborns with regards to tidal volume , peak inspiratory pressure variability,or inflammatory cytokines. Therefore in this study the investigators aimed to compare these two ventilation modes with regards to short term outcome.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Both
Age group N/A to 24 Hours
Eligibility Inclusion Criteria:

- neonates with respiratory distress who need mechanical ventilation

- gestational age less than or equal to 37 weeks

- neonates who need mechanical ventilation within first 24 hours

Exclusion Criteria:

- neonates who need mechanical ventilation other than conventional ventilation

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Intervention

Other:
SIMV+VG mode of ventilation (synchronized intermittent mandatory ventilation+volume guarantee)
Neonates who need mechanical ventilation will be ventilated with SIMV+VG mode
PSV+VG (pressure support ventilation+volume guarantee)
Neonates who need mechanical ventilation will be ventilated with PSV+VG

Locations

Country Name City State
Turkey Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine Besevler Ankara

Sponsors (1)

Lead Sponsor Collaborator
Gazi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary IL-1beta levels in tracheal aspirate material Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported Baseline and 72 hours of mechanical ventilation No
Primary IL-6 level in tracheal aspirate Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported Baseline and 72 hours of mechanical ventilation No
Primary IL-8 in tracheal aspirate material Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported Baseline and 72 hours of mechanical ventilation No
Primary IL-10 level in tracheal aspirate material Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported Baseline and 72 hours of mechanical ventilation No
Primary TNF alfa in tracheal aspirate material Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported Baseline and 72 hours of mechanical ventilation No
Primary tidal volume variability variability in tidal volume measured with babyview program 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary peak inspiratory pressure variability variability in peak inspiratory pressure measured with babyview program 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary respiratory rate variability changes in respiratory rate, tacypnea rate 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary oxygen saturation variability changes in oxygen saturation, desaturation rate, hyperoxy rate 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary lowest carbondioxide level (mmHg) ratio of hypocarbic blood gases and least pCo2 level 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary highest carbondioxide level (mmHg) ratio of hypercarbic blood gases and highest pCo2 level 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary lowest oxygen level (mmHg) ratio of hypoxic blood gases and least pO2 level 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Primary highest oxygen level (mmHg) ratio of hyperoxic blood gases and highest pO2 level 72 hours of mechanical ventilation or entire ventilation time if extubated earlier Yes
Secondary bronchopulmonary dysplasia Oxygen requirement at 36 weeks corrected age 36 weeks corrected age Yes
Secondary patent ductus arteriosus Presence of hemodynamically significant patent ductus arteriosus in the first 7 days of life in the first week of post natal life of the patient No
Secondary necrotizing enterocolitis Necrotising entercolitis defined by clinical and radiological findings 36 weeks corrected age No
Secondary intraventricular hemorrhage Intraventricular hemorrhage diagnosed by head ultrasound during first week Yes
Secondary pneumothorax Air leak diagnosed by chest x-ray during first 3 days Yes
Secondary pulmonary interstitial emphysema Air leak diagnosed by x-ray during first week Yes
Secondary pulmonary hemorrhage during first week Yes
Secondary retinopathy of prematurity Retinal disease diagnosed by indirect opthtalmoscopic exam until 36 weeks corrected age No
See also
  Status Clinical Trial Phase
Completed NCT02670460 - Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial N/A
Recruiting NCT01502332 - Intensive Alveolar Recruitment Protocol After Cardiac Surgery N/A
Active, not recruiting NCT01959009 - High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation N/A